Kazakhstan vs South Africa: Cases started on MDR-TB treatment
Kazakhstan
4,641
in 2024
South Africa
6,578
in 2024
Kazakhstan rank
7th
South Africa rank
6th
Cases started on MDR-TB treatment over time
- Kazakhstan
- South Africa
How they compare
South Africa currently reports 6,578 against 4,641 in Kazakhstan, a difference of 1,937.
That makes South Africa's figure about 1.4 times Kazakhstan's.
The two have swapped places 4 times across 16 shared years of data; in 2009 it was South Africa ahead.
Kazakhstan ranks 7th and South Africa ranks 6th of 193 countries.
South Africa has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3,209 | 4,143 | 934 | South Africa |
| 2010s | 6,228 | 9,190 | 2,962 | South Africa |
| 2020s | 4,665 | 7,179 | 2,514 | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Kazakhstan or South Africa?
- South Africa, at 6,578 against 4,641 in Kazakhstan as of 2024.
- What is the difference in cases started on mdr-tb treatment between Kazakhstan and South Africa?
- 1,937, with South Africa ahead.
- How many years of comparable data are there for Kazakhstan and South Africa?
- 16 years are reported by both, from 2009 to 2024.
- How do Kazakhstan and South Africa rank globally for cases started on mdr-tb treatment?
- Kazakhstan ranks 7th and South Africa ranks 6th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.